Items where Funder is Aventis Pharma Limited.

[up] Up a level
Group by: Grant number | Institution | No Grouping
Number of items: 1.

Royle, K-L orcid.org/0000-0003-0225-1199, Coulson, AB, Ramasamy, K et al. (26 more authors) (2022) Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trial. BMJ Open, 12 (11). e063037. ISSN 2044-6055

This list was generated on Sun Apr 6 10:52:28 2025 BST.